Followers | 40 |
Posts | 1920 |
Boards Moderated | 0 |
Alias Born | 11/08/2011 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, October 24, 2012 9:52:54 AM
The only related news stated in the press release is that "Rainbow BioSciences nears a deal with Amarantus BioSciences" - this is the same rehashed press release that we have been hearing for several months out of RBCC stating they are "near" or "hope" to have a deal in place "soon". What matters to investors is an "actual" deal.
The kicker is that RBCC considers itself a competitor to AMGN, CTIC, ABT, and AFFY - huh?? Under what criteria? Should assets, expertise, employees, revenue, capital, and an actual product be considered as criteria?
FEATURED Element79 Gold Corp Appoints Warren Levy to Board of Directors • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM